Media Highlights and Announcements

Proactive InvestorsJune 27, 2022

A theatre of human innovation

For medtech entrepreneur and Artrya Ltd CEO John Barrington, every good solution to a problem starts with a clean sheet of paper and a little bit of human ingenuity.

Learn More

Stockhead host Peter Strachan discusses Artrya’s Salix technology and how through the use of big data and AI it can accurately detect markers and indicators of early heart disease.

Learn More

Cardiac software provider Artrya is partnering with Huntsville Heart Center to test the efficacy of its AI-based technology in caring for cardiac patients.

Learn More

Initial agreement includes comparison study of patient cardiac CT scans read by experts to those read by AI-based technology.

Learn More

Under an initial agreement, Huntsville Heart Center and Artyra will compare patient cardiac CT scans read by experts to those read by artificial intelligence (AI)-based technology.

Learn More

Artrya’s MD, John Barrington AM discusses the company’s first US partnership deal with Proactive’s Andrew Scott, detailing a clinical agreement with Huntsville Heart Center.

Learn More

A leading Perth cardiologist believes the recent spate of high-profile heart attacks should sound a warning about the increased health risks associated with modern living.

Learn More

ArtryaApril 22, 2022

AI-Driven HealthTech

Ticker Insight News interviews John Barrington AM, on Artrya’s US expansion and the growing MedTech sector in Western Australia.

Learn More

John Barrington discusses the company’s move into the US market, and its use of artificial intelligence in diagnosing early indicators for heart disease in clinical settings.

Learn More

Artrya Ltd announced the appointment of US Cardiologist Nicolas Chronos, MD, to its Clinical Advisory Board. He will promote key medical research partnerships and oversee US based research in support of Artrya’s US market entry.

Learn More